Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Stroke. 2012 May 8;43(7):1925–1930. doi: 10.1161/STROKEAHA.111.647982

Figure 1.

Figure 1

Human antibody was detected in the brain parenchyma of mice treated with bevacizumab and trastuzumab. Vessels are labeled with lectin (green). Human IgG (red) was detected only in VEGF-stimulated regions of mice treated with bevacizumab and trastuzumab. Inserts show high magnification images of vessels. Scale bar: 100 μm.